NOVEL - NANOS Annual Meeting
 
Filters: Collection: ehsl_novel_nam
1 - 25 of 4
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Treatment of Retinal DisordersGuy JirawuthiworavongApproximately 0.1% to 0.5% of patients of middle age and older will suffer from a central retinal vein occlusion. Vision loss can be devastating rendering patients to be legally blind in the affected eye. The Central Vein Occlusion Study published in 1997 showed that patients presenting with less th...20130211_nanos_journalclubsympos_01-1
2 Treatment of Retinal DisordersGuy JirawuthiworavongApproximately 0.1% to 0.5% of patients of middle age and older will suffer from a central retinal vein occlusion. Vision loss can be devastating rendering patients to be legally blind in the affected eye. The Central Vein Occlusion Study published in 1997 showed that patients presenting with less th...20130211_nanos_journalclubsympos_01-2
3 Treatment of Retinal DisordersGuy JirawuthiworavongApproximately 0.1% to 0.5% of patients of middle age and older will suffer from a central retinal vein occlusion. Vision loss can be devastating rendering patients to be legally blind in the affected eye. The Central Vein Occlusion Study published in 1997 showed that patients presenting with less th...20130211_nanos_journalclubsympos_01-2
4 Treatment of Retinal DisordersGuy JirawuthiworavongApproximately 0.1% to 0.5% of patients of middle age and older will suffer from a central retinal vein occlusion. Vision loss can be devastating rendering patients to be legally blind in the affected eye. The Central Vein Occlusion Study published in 1997 showed that patients presenting with less th...20130211_nanos_journalclubsympos_01
1 - 25 of 4